Norway’s Crown Princess Mette-Marit is facing a worsening battle with pulmonary fibrosis, forcing royal officials to acknowledge her increasing limitations and prepare the public for changes to her royal duties.
At a Glance
- Crown Princess Mette-Marit of Norway is experiencing a progression of pulmonary fibrosis, an incurable lung disease first diagnosed in 2018
- The royal palace announced her condition now requires more rest and will cause more frequent, short-notice changes to her official schedule
- Her daily symptoms affect her ability to perform royal duties, resulting in several weeks of sick leave in both 2023 and 2024
- Despite health challenges, the Crown Princess has expressed determination to continue her work with necessary adjustments
A Royal Health Crisis
The Norwegian royal family is adapting to a difficult new reality as Crown Princess Mette-Marit’s chronic lung disease worsens. The Royal House of Norway recently confirmed that the progression of her pulmonary fibrosis has intensified, requiring significant adjustments to her daily routine and royal obligations. Diagnosed in October 2018, the 51-year-old Princess is experiencing more severe daily symptoms that directly impact her capacity to fulfill her role as wife to Crown Prince Haakon, heir to the Norwegian throne.
Pulmonary fibrosis causes progressive scarring of lung tissue, making breathing increasingly difficult. The condition varies in its progression – some patients remain stable for extended periods, while others deteriorate rapidly. For the Crown Princess, recent developments indicate her condition is advancing, necessitating more comprehensive adjustments to her schedule.
Changes to Royal Responsibilities
The palace has been forthright about the challenges facing the future queen consort. In the past year, these health issues have already caused noticeable disruptions to her public duties. The Crown Princess took several weeks of sick leave in September 2023 and again in October 2024, canceling numerous public appearances.
Despite these challenges, palace officials have emphasized that the Crown Princess remains committed to her work. Accommodations are being made to balance her health requirements with her commitment to public service. The royal household is planning for periods without an official program when her treatment needs intensify or when the disease becomes more active, allowing her necessary recovery time between engagements.
Facing Mortality and Moving Forward
Mette-Marit has shown remarkable candor about her health journey. In an August 2023 interview as she approached her 50th birthday, she reflected on her changed perspective. “When you get to be 50, you understand that life is not eternal,” she said.
While pulmonary fibrosis has no cure, various treatments can slow its progression and improve quality of life. For some patients, lung transplantation eventually becomes a consideration when other therapies prove insufficient. The palace has not disclosed specific details about the Crown Princess’s treatment protocol.
The Norwegian people have largely responded with sympathy and support for the Crown Princess, recognizing her determination to continue serving whenever her health permits.
